Citadel Advisors’s OS Therapies OSTX Stock Holding History
Bought
Maintained
Sold
Other funds holding OSTX
Citadel Advisors's OSTX Position: Q3 2026 in Review
Citadel Advisors opened a new position in OS Therapies (OSTX) in Q3 2026: 245,856 shares worth $393K. The stake represents ﹤0.01% of the portfolio and ranks #10770 among its holdings.
32 funds tracked by Wall St. Rank hold OSTX as of Q3 2026.
- Citadel Advisors held 245,856 shares of OS Therapies worth $393K as of Q3 2026.
- OS Therapies was a new Citadel Advisors position in Q3 2026.
- OS Therapies made up ﹤0.01% of Citadel Advisors's portfolio in Q3 2026, its #10770 holding.
- 32 funds tracked by Wall St. Rank held OS Therapies as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.